S-{1-[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} 3-(4-hydroxyphenyl)prop-2-enethioate (non-prefe,185532-73-4 Products Supply

Name: S-{1-[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} 3-(4-hydroxyphenyl)prop-2-enethioate (non-prefe
CAS NO.: 185532-73-4
Synonyms:
Cumic alcohol;cuminyl alcohol;cuminic alcohol;Cuminol;4-isopropylbenzyl alcohol;p-Cymen-7-ol;Cumyl alcohol;p-cumic alcohol;CUMIN ALCOHOL;p-Isopropylbenzyl alcohol;Benzenemethanol, 4-(1-methylethyl)-;536-60-7;Benzyl alcohol, p-isopropyl-;4-(1-Methylethyl)benzenemethanol;(4-Isopropylphenyl)methanol;FEMA No. 2933;4-(1-methylethyl)-benzenemethanol;4-(1-methylethyl)benzene methanol;EINECS 208-640-4;NSC 15672;BRN 0636665;AI3-20440;Cuminylalcohol;AC1Q1ONU;bmse000599;AC1L18ZM;UNII-V261W8XR62;W293318_ALDRICH;(4-propan-2-ylphenyl)methanol;196037_ALDRICH;AC1Q7C82;WLN: Q1R DY1&1;4-ISOPROPYLBENZENEMETHANOL;OIGWAXDAPKFNCQ-UHFFFAOYSA-;p-ISOPROPYL BENZYL ALCOHOL;MolPort-001-766-696;HMS1789P06;[4-(Propan-2-Yl)Phenyl]Methanol;CPD-1002;NSC15672;AR-1I2763;c0376;NSC-15672;SBB065188;ZINC00968247;AKOS000121600;LS-2865;NCGC00249151-01;I0272;C06576;I01-7255;InChI=1/C10H14O/c1-8(2)10-5-3-9(7-11)4-6-10/h3-6,8,11H,7H2,1-2H3;185532-73-4
Molecular Structure:
Molecular Formula: C₃₀H₄₂N₇O₁₈P₃S

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: S-{1-[5-(6-amino-9H-purin-9-yl; S-{1-[5-(6-amino-9H-purin-9-yl; S-{(9R)-1-[(2R,3S,4R,5R)-5-(6-; S-{(9R)-1-[(2R,3S,4R,5R)-5-(6-; S-{(9R)-1-[(2R,3S,4R)-5-(6-ami; S-{(9R)-1-[(2R,3S,4R,5R)-5-(6-; S-{(3S,5R)-1-[(2R,3S,4R,5R)-5-; S-{(9R)-1-[(2R,3S,4R,5R)-5-(6-; S-{17-[5-(6-amino-9H-purin-9-y; S-{(9R)-17-[(2R,3S,4R,5R)-5-(6; S-{(9R)-17-[(2R,3S,4R,5R)-5-(6; S-{(13R,15S)-17-[(2R,3S,4R,5R); (20E)-1-[(2R,3S,4R,5R)-5-(6-am; [(2R,3S,4R,5R)-5-[6-({2-[(6-am; (21E)-1-[(2R,3S,4R,5R)-5-(6-am; (9R)-1-[(2R,3S,4R,5R)-5-(6-ami; [5-(6-amino-9H-purin-9-yl)-4-h; [(2R,3S,4R,5R)-5-(6-amino-9H-p; 1/C11H14N2O6/c1-17-7(14)4-12-2; 1/C15H10O4/c16-11-7-3-1-5-9(11; [5-(4-amino-2-oxo-pyrimidin-1-; N-{5-[6-(dimethylamino)-9H-pur; 2-amino-N-[5-(6-amino-9H-purin; sodium (2R,3S,4R)-5-(2-amino-6; 1/C11H18O4/c1-14-10(12)8-5-3-4; 1/C12H10N4O3/c1-3-19-12(18)10-; 1/C11H9N5O/c1-17-6-2-3-8-9(4-6; S-(10-{[(2S,5R)-5-(6-amino-9H-; (2R)-2-[(9-{(2R,3R,4S,5R)-3,4-; 1/C15H13NO/c1-2-16-14-6-4-3-5-;